INTS
Intensity Therapeutics, Inc. Common stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Intensity Therapeutics (INTS) Stock: Buy, Sell, or Hold?
$3.10
-0.18 (-5.49%)
▼
5d:
+0.0%
30d:
-9.36%
90d:
-21.72%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
48/100
Position
OVERSOLD
30-Day Fair Range
$3.15 – $3.53
Position: OVERSOLD
Forward P/E & Valuation
-1.4x
Next 12M consensus est.
Wall Street Target
$18.67
+502.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.80 / $3.58
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: INTS shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When INTS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: INTS is currently trading at $3.10, which is considered oversold relative to its 30-day fair value range of $3.15 to $3.53.
Technical Outlook: Technically, INTS is in a strong downtrend. Immediate support is located at $2.80, while resistance sits at $3.58. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: INTS scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.67 (+502.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INTS is in a strong downtrend. Immediate support is located at $2.80, while resistance sits at $3.58. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: INTS scores 73/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $18.67 (+502.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.15 -
$3.53
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.5%
Trading Range & Key Levels
30-Day Trading Range
$3.15 -
$3.53
Current vs Trading Range
OVERSOLD
Support Level
$2.80
Resistance Level
$3.58
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (73/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 502.2% below Wall St target ($18.67)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-1.40
Wall Street Target
$18.67
(+502.2%)
Share INTS Analysis
Share this live INTS analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (INTS)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 23, 2026
Daily AI digest
AI Retail Discussion Summary:
StockTwits users expressed bullish sentiment regarding potential positive movement for $INTS, but no recent news articles were found.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 5:52 AM ET
Data refreshes hourly during market hours. Next update: 6:52 AM
Data refreshes hourly during market hours. Next update: 6:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INTS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 38 SELL |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 41 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 42 HOLD |
|
SNDX
Syndax Pharmaceuticals I… |
STRONG BUY
12 analysts |
$35 | 58 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive INTS Research Pages
